Alpha 2.0
Login Register
» Articles » PMID: 30612920

Guillain-Barré Syndrome Related to Nivolumab: Case Report of a Patient With Urothelial Cancer and Review of the Literature

Overview
Journal Clin Genitourin Cancer
Publisher Elsevier
Specialties Oncology
Urology
Date 2019 Jan 8
PMID 30612920
Citations 5
Authors
Anastasios Kyriazoglou
Michael Liontos
Costantinos Papadopoulos
Afroditi Bilali
Euthymios Kostouros
Stamatina Pagoni
Konstantinos Doumas
Meletios Athanasios Dimopoulos
Aristotelis Bamias
Affiliations
Soon will be listed here.
Citing Articles

Immune Checkpoint Inhibitor-Induced Guillain Barre Syndrome: A Single-Institution Case Report and Narrative Review.

Idogun P, Hafez-Khayyata S, Ezekwudo D Cureus. 2024; 16(6):e61489.

PMID: 38952584 PMC: 11216129. DOI: 10.7759/cureus.61489.

Guillain-Barré Syndrome-Like Polyneuropathy Associated with Immune Checkpoint Inhibitors: A Systematic Review of 33 Cases.

Li Y, Zhang X, Zhao C Biomed Res Int. 2021; 2021:9800488.

PMID: 34458371 PMC: 8390151. DOI: 10.1155/2021/9800488.

Atezolizumab-induced encephalitis in a patient with metastatic breast cancer: a case report and review of neurological adverse events associated with checkpoint inhibitors.

Nader R, Tannoury E, Rizk T, Ghanem H Autops Case Rep. 2021; 11:e2021261.

PMID: 33968830 PMC: 8087350. DOI: 10.4322/acr.2021.261.

Guillain-Barre syndrome induced by pembrolizumab and sunitinib: A case report.

Han C, Ma J, Zhang Y, Jiang Y, Hu C, Wu Y Mol Clin Oncol. 2020; 13(1):38-42.

PMID: 32499912 PMC: 7265222. DOI: 10.3892/mco.2020.2042.

Safe Transition to Pembrolizumab following Ipilimumab-Induced Guillain-Barré Syndrome: A Case Report and Review of the Literature.

Gravbrot N, Scherer K, Sundararajan S Case Rep Oncol Med. 2019; 2019:5490707.

PMID: 31885974 PMC: 6893263. DOI: 10.1155/2019/5490707.